PUBLISHER: Grand View Research | PRODUCT CODE: 1908236
PUBLISHER: Grand View Research | PRODUCT CODE: 1908236
The global capsule endoscopy market size was estimated at USD 475.69 million in 2025 and is projected to reach USD 880.51 million by 2033, growing at a CAGR of 8.06% from 2026 to 2033. The increasing prevalence of Gastrointestinal (GI) diseases & colon cancer, rising demand for minimally invasive diagnostic procedures, and introduction of technologically advanced capsule endoscopes are the major factors driving the market.
For instance, according to the Canadian Cancer Society, colorectal cancer is expected to be the 4th most commonly diagnosed cancer in Canada in 2024. As per estimates provided by the Canadian Cancer Society, 25,200 Canadians were diagnosed with colorectal cancer, which represented 10% of all new cancer cases in 2024.
As awareness of the clinical benefits of capsule endoscopy, patient convenience, and diagnostic accuracy continues to rise, more hospitals and healthcare providers are incorporating capsule endoscopy into their gastroenterology services. This adoption is driven by the demand for minimally invasive diagnostic procedures, especially for conditions that are difficult to diagnose with traditional endoscopy. Hospitals are increasingly investing in capsule endoscopy technology as it provides detailed imaging of the entire small intestine. The following are the several hospitals that offer capsule endoscopy services
Global Capsule Endoscopy Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global capsule endoscopy market report based on type, application, end use, and region: